No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs7045601 |
chr9:26722736-26722737 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs537568485 |
chr9:26722756-26722757 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs549480452 |
chr9:26722769-26722770 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs567726071 |
chr9:26722813-26722814 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs116213277 |
chr9:26722824-26722825 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs115237736 |
chr9:26722834-26722835 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs10812450 |
chr9:26722838-26722839 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs201079418 |
chr9:26722848-26722849 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs539312382 |
chr9:26722866-26722867 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs557181086 |
chr9:26722876-26722877 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs576077037 |
chr9:26722900-26722901 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs575412638 |
chr9:26722966-26722967 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs114060829 |
chr9:26723001-26723002 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs561463559 |
chr9:26723004-26723005 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs183746880 |
chr9:26723026-26723027 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs139831032 |
chr9:26723110-26723111 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs559291084 |
chr9:26723123-26723124 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs572722539 |
chr9:26723152-26723153 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs74311904 |
chr9:26723167-26723168 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs140967407 |
chr9:26723183-26723184 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs186926997 |
chr9:26723199-26723200 |
Weak transcription Enhancers Bivalent/Poised TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs193008181 |
chr9:26723205-26723206 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs144100493 |
chr9:26723232-26723233 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs111474045 |
chr9:26723250-26723251 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs543027122 |
chr9:26723256-26723257 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs370874958 |
chr9:26723266-26723267 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs7035173 |
chr9:26723273-26723274 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs374580668 |
chr9:26723286-26723287 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs567767270 |
chr9:26723310-26723311 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs535078908 |
chr9:26723333-26723334 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs546720365 |
chr9:26723334-26723335 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs7018883 |
chr9:26723349-26723350 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs113174856 |
chr9:26723362-26723363 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs147338423 |
chr9:26723372-26723373 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs2043465 |
chr9:26723380-26723381 |
Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs575499425 |
chr9:26723400-26723401 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs536469473 |
chr9:26723439-26723440 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs532142402 |
chr9:26723442-26723443 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs554702991 |
chr9:26723465-26723466 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs573695336 |
chr9:26723501-26723502 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs10967494 |
chr9:26723522-26723523 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
42 |
rs141012181 |
chr9:26723570-26723571 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs577549400 |
chr9:26723590-26723591 |
Active TSS Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs544984674 |
chr9:26723629-26723630 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs11791320 |
chr9:26723658-26723659 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs4531131 |
chr9:26723702-26723703 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs562685535 |
chr9:26723724-26723725 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs111816026 |
chr9:26723759-26723760 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs541887858 |
chr9:26723780-26723781 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs547051897 |
chr9:26723784-26723785 |
Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|